Stockscreener 앱 받기
9.59
1.70%
0.16
전일 마감가:
$9.43
열려 있는:
$9.33
하루 거래량:
44,517
Relative Volume:
0.48
시가총액:
$89.78M
수익:
$24.99M
순이익/손실:
$-108.83M
주가수익비율:
-0.6381
EPS:
-15.0286
순현금흐름:
$-91.62M
1주 성능:
+5.85%
1개월 성능:
+4.13%
6개월 성능:
+26.68%
1년 성능:
-15.96%
1일 변동 폭
$9.261
$9.76
1주일 범위
$8.62
$9.76
52주 변동 폭
$6.01
$17.44
Adicet Bio Inc Stock (ACET) Company Profile
명칭
Adicet Bio Inc
전화
617-482-2333
주소
131 DARTMOUTH STREET, BOSTON
Compare ACET vs VRTX, REGN, ARGX, MRNA, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
9.59 | 87.81M | 24.99M | -108.83M | -91.62M | -15.03 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-30 | 재개 | Guggenheim | Buy |
| 2024-09-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-03-31 | 개시 | SMBC Nikko | Outperform |
| 2022-03-08 | 개시 | Truist | Buy |
| 2022-03-04 | 개시 | Jefferies | Buy |
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-23 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Canaccord Genuity | Buy |
| 2021-04-08 | 개시 | Guggenheim | Buy |
| 2020-11-04 | 개시 | B. Riley Securities | Buy |
| 2020-10-27 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-16 | 개시 | Wedbush | Outperform |
모두보기
Adicet Bio Inc 주식(ACET)의 최신 뉴스
ETFs Investing in Adicet Bio Inc Stocks - TradingView
Are Medical Stocks Lagging Adicet Bio (ACET) This Year? - Yahoo Finance
ACET Q2 2026 Earnings: Narrower-Than-Expected Loss of $1.99 Per Share Buoys SharesSegment Revenue Breakdown - vinanet.vn
RA Capital discloses 9.99% Adicet Bio (ACET) stake with warrant blocker - Stock Titan
Adicet Bio (ACET) - Zacks Investment Research
Adicet Bio: A Cheap Gamma Delta T-Cell Play (NASDAQ:ACET) - Seeking Alpha
Wall Street Analysts Think Adicet Bio (ACET) Could Surge 301.57%: Read This Before Placing a Bet - Zacks Investment Research
Adicet Bio's CAR-T therapy shows promise for au... - Pluang
Adicet Bio (ACET) Edges Higher to $8.26 as Biotech Stock Consolidates Between Key LevelsETF Flow - Vinanet
HC Wainwright Has Strong Estimate for Adicet Bio Q3 Earnings - MarketBeat
Adicet Bio at Canaccord Genuity: lupus data drives next step By Investing.com - Investing.com Canada
Adicet Bio Eyes Key Lupus Data This Quarter for Off-the-Shelf Cell Therapy - MarketBeat
All You Need to Know About Adicet Bio (ACET) Rating Upgrade to Buy - newsbreak.com
H.C. Wainwright Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $27 - Moomoo
JonesTrading Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Price to sales forward of Adicet Bio, Inc. – NASDAQ:ACET - TradingView
Adicet Bio Inc (ACET) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Press Release Service: Adicet Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates - CRISPR Medicine News
Guggenheim cuts Adicet Bio stock price target to $90 on cash position - Investing.com UK
CCORF Maintains Adicet Bio(ACET.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Adicet Bio, Inc. Stock 12‑Month Price Target Cut to $34.4, Implies 276% Upside - TradingView
ADICET BIO Q2 NET INCOME USD -21.358 MILLION - Moomoo
ADICET Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Adicet Bio (NASDAQ:ACET) Posts Earnings Results, Misses Estimates By $0.30 EPS - MarketBeat
Adicet Bio Q2 net loss narrows - TradingView
Adicet Bio reports Q2 2026 net loss $21.4M; cash runway into H2 2027, clinical updates planned - TradingView
Adicet Bio, Inc. 2Q 2026: Revenue $0 Net loss $(21.4)M, EPS $(1.99) — 10-Q Summary - TradingView
ACET: Q2 2026 net loss narrowed 32% year-over-year; cash runway extends into H2 2027 - TradingView
BRIEF-Adicet Bio Q2 Basic EPS USD -1.99 - TradingView
ACET Q2'26 Earnings: EPS estimate is (1.69) USD - tradingview.com
More Than Two Decades at Johnson & Johnson: Lipocine's New Director - stocktitan.net
Adicet Bio Inc expected to post a loss of $2.03 a shareEarnings Preview - TradingView
ACET Q1 2026 Earnings: Narrower Loss Beats Estimates by 40.74% as Clinical Pipeline AdvancesConsensus Miss Rate - vinanet.vn
Adicet Bio Inc Actuals & Estimates (NASDAQ:ACET) - TradingView
Adicet Bio (NASDAQ:ACET) Share Price Passes Above 200 Day Moving AverageTime to Sell? - MarketBeat
Adicet Bio, Inc. Revenue Breakdown – NASDAQ:ACET - TradingView
Adicet Bio Inc (ACET) Balance Sheet - TradingKey
Adicet Bio Inc (ACET) Cash Flow - TradingKey
Adicet Bio: A 400% Upside Bet on Gamma Delta T-Cell Data - Kavout | AI
Adicet Bio Inc Revenue Breakdown – TRADEGATE:1IJ - TradingView
Adicet Bio Inc (ACET) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Adicet Bio Inc (ACET) Income Statement - TradingKey
Adicet Bio Inc (ACET) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Adicet Bio Inc (ACET) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Adicet Bio Inc (ACET) Valuation: PE, PB & Fair Value Analysis - TradingKey
ACET|Adicet Bio Inc|Price:8.140|Chg%:+0.350 - TradingKey
Adicet Bio Market Sentiment - Benzinga España
Adicet Bio (ACET) Faces Pressure as Shares Slide Over 7% – Key Levels in FocusCatalyst Driven Stocks - vinanet.vn
ACET Q1 2026 Earnings: EPS Surprise of 40.7% Mitigates Quarterly Loss, Shares Trade LowerOne-Time Loss Impact - vinanet.vn
ACET Q1 2026 Earnings: Narrower-Than-Expected Loss Drives 5.54% Share Price GainPost-Earnings Drift - vinanet.vn
Adicet Bio to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference - BioSpace
Adicet Bio Inc (ACET) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Adicet Bio Inc 주식 (ACET) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Feb 19 '26 |
Buy |
7.21 |
74,268 |
535,472 |
1,107,873 |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner |
Feb 18 '26 |
Buy |
7.04 |
74,577 |
525,022 |
1,033,605 |
| ORBIMED ADVISORS LLC | 10% Owner |
Apr 08 '26 |
Sale |
6.42 |
72,939 |
468,082 |
0 |
| ORBIMED ADVISORS LLC | 10% Owner |
Apr 07 '26 |
Sale |
6.52 |
31,719 |
206,765 |
32,523 |
0.86%
0.31%
자본화:
|
볼륨(24시간):